SlideShare a Scribd company logo
1
Application for Accreditation of Foreign Manufacturers
(This English document is only for reference purpose. In case of any discrepancy, the Japanese
text shall prevail. For further information, please contact Ministry of Health, Labour and Welfare
(MHLW) or PMDA.)
1. What is Accreditation of Foreign Manufacturers?
A foreign manufacturer (a person/a company) intending to manufacture drugs, quasi-
drugs, or medical devices in foreign countries and export them to Japan, is required to
be accredited by the Minister of Health, Labour, and Welfare as an “Accredited Foreign
Manufacturer”, specified in Article 13-3 of PAL, in the same way that a Japanese
manufacturer is licensed. The person or the company who intends to apply for the
accreditation is hereinafter referred to as an “Applicant”.
However, a foreign manufacturer of the drug or medical device, etc. whose marketing
approval holder has an effective importing license granted under the old PAL as of April
1, 2005, is deemed to be temporarily accredited under the revised PAL by the end of its
effective period. The manufacturer satisfying the above condition is hereinafter
referred to as a “Deemed Accredited Foreign Manufacturer”.
In addition, a foreign manufacturer intending to manufacture only drug substances to be
exported to Japan also need to obtain accreditation as an “Accredited Foreign
Manufacturer”. The Minister of Health, Labour and Welfare has an authority to grant
accreditation to a foreign manufacturer, while PMDAexamines buildings and facilities of
the manufacturing establishment for accreditation. The accreditation is granted for
each manufacturing establishment according to the category specified by the
Enforcement Regulations.
Before applying for accreditation, a Japanese marketing approval holder for an
“Applicant” needs to submit “Business Number Registration Form”, reporting information
on the applicant’s business and manufacturing establishments, in order to obtain
“Business Number”.
2. Application for Accreditation of ForeignManufacturers
(1) An “Applicant” is required to submit “Application for Accreditation” (Form No. 18 in
the PAL Enforcement Regulations) that is addressed to the Minister in duplicate,
and “Application for Accreditation Examination” (Form No.16-(2) in the Regulations)
to Chief Executive of PMDA. Both applications need to be submitted to
Administration Division II, Office of Review Administration of PMDA.
A Japanese marketing approval holder who markets drugs and medical devices, etc.
2
manufactured by a foreign manufacturer can make an accreditation application on
the manufacturer’s behalf. However, the space of “Name of Applicant” on the
application form should be filled out with the foreign manufacturer’s name (when an
“Applicant” is a corporation, names of the corporation and their CEO). In addition,
an “Applicant” is to be responsible to renew their accreditation every 5 years. For
more details on the renewal procedure, please refer to 2-(4), “Application for
Renewal of Accreditation of Foreign Manufacturers”.
Examination Fees for the accreditation differ between on-site and document
examinations. However, PMDA requires only document audit fee to be paid to our
bank account because, in principle, we do not conduct on-site inspection only for the
purpose of examining buildings and facilities of a foreign manufacturing
establishment to be accredited.
A target period to complete administrative processing (standard administrative
process time) of accrediting a foreign manufacturer is not specifically set. However,
the period can be estimated to be about 5 months because the Minister’s licensing
process for a domestic manufacturing establishment takes about 5 months.
When an “Applicant” intends to apply for a new accreditation, they cannot apply for
multiple categories in one accreditation application. They need to submit an
accreditation application for one category and, at the same time, submit additional
applications for the other categories (ref. 2-(3), Application for Change/Addition in
Category of Accreditation of Foreign Manufacturers).
(2) Documents to Be Attached to Accreditation Application (Article 35, Paragraph
2 of the PAL Enforcement Regulations)
Ⓒ ”A medical certificate from a physician which indicates whether or not an “Applicant”
has mental disorders or is addicted to narcotics, cannabis, opium or stimulant drugs”.
(When the “Applicant” is a corporation, medical certificates of their CEO and all the
executives responsible for the services are required.)
A medical certificate and the other required documents for accreditation can be
written in any language, but their Japanese translations are required. The
reference of translator is needed only when they are written in other languages than
English.
When the “Applicant” is a corporation, and the Minister of Health Labour and
Welfare recognizes that the above medical certificate form a physician is not an
absolute necessity taking the responsible services of the executives into
3
consideration, a signed written statement that the relevant executives are not fall
under item 3 (d) (excluding the provision of adult ward) and (e) of Article 5 of PAL
can be submitted.
Ⓒ “A curriculum vitae of the person who is responsible to the manufacturing
establishment”
Ⓒ “List of products” to be manufactured for exporting to Japan and “Documents on
manufacturing process”
Please make a list of products to be manufactured as detail as you can figure out by
the time of accreditation application. In a “Document on manufacturing process”,
please organize it clearly that each of the listed products will take what/which type of
manufacturing procedure at the relevant establishment.
④ “Adocument on buildings and facilities of a manufacturing establishment”
An “Applicant” intending to manufacture drugs (excluding in vitro diagnostics) and
quasi-drugs needs to submit documents equivalent to the application documents
for manufacturing license of drugs and quasi-drugs specified in “Enforcement of
Ministerial Ordinance etc. of Partial Revision of the Regulations for Manufacturing
Control and Quality Control of Drugs and Regulations for Buildings and Facilities for
Pharmacies, etc.” (PAB Notification No. 1332, dated October 9, 1980).
In addition, they need to submit informative documents for examination of buildings
and facilities of their manufacturing establishments such as a floor plan.
⑤ “When radiopharmaceuticals are included (excluding cases that the amount of
radiopharmaceuticals is equal to or less than those designated by the Minister), a
document on the type of the radiopharmaceuticals and outlines of facilities for
handling such radiopharmaceuticals”
⑥ “When a system for marketing license, manufacturing license, marketing approval or
marketing certification of drugs and medical devices or an equivalent system is
established in the country where the foreign manufacturer resides, a copy of the
license certificate issued by governmental organizations etc. of the country under
such system”. The license certificate should be currently valid.
Note 1: Points to Consider (PTC) with Respect to Accreditation of Foreign
4
Manufacturers of Quasi-drugs
“A medical certificate for an “Applicant” from a physician” and “a curriculum vitae of
the person who is responsible for the foreign manufacturing establishment” do not
need to be attached to an application form for accreditation of foreign manufacturers,
when the marketing approval holder concerned responsibly ensures their reliability.
In this case, the “Applicant” can omit filling out the space of “Address” in the section
of “Person who is responsible for manufacturing establishment” and “Conditions of
Disqualification of applicant” on the application form.
In addition, the “Applicant” needs to indicate the status of their intended products by
showing either “Quasi-drug Subject to GMP” or “Quasi-drug Not Subject to GMP” in
the remarks column.
Note 2: Points to Consider (PTC) with Respect to Accreditation of Foreign
Manufacturers of Medical Devices and In vitro Diagnostics
When an “Applicant” has reasonable and convincing reasons why they have
difficulties to obtain their medical certificate from a physician in the country where
they reside, they can submit a written self-declaration instead of a medical
certificate.
(3) Application for Change/Addition in Categoryof Accreditation of Foreign
Manufacturers
When an “Accredited Foreign Manufacturer” changes the category accredited to
their manufacturing establishment or adds new categories to their accreditation,
they must submit a form, “Application for Change/Addition” (Form No. 21 specified in
the PAL Enforcement Regulations), in order to newly obtain the Minister’s
accreditation for the change or addition.
When the manufacturer intends to add new categories to their accreditation, they
need to apply for addition in accreditation category.
On the other hand, applying for change in category of accreditation allows the
manufacturer to be accredited to new categories while cancelling their previously
accredited categories.
In both of the cases, the manufacturer also needs to submit a form of “Application
for Accreditation Examination” (Form No. 16-(2) in the Regulations) in the same way
of a new application as referred to in 2-(1) above.
The documents required for change or addition in category of accreditation of
5
foreign manufacturers are as follows; (Article 31 of the PAL Enforcement
Regulations shall apply mutatis mutandis to Article 37.)
1. Accreditation certificate
2. List of products whose accreditation category to be changed or added and
documents on their manufacturing processes
3. Documents on buildings and facilities of a manufacturing establishment that
relates to change or addition in category of accreditation
(4) Application for Renewal of Accreditation of Foreign Manufacturers
Unless an “Accredited Foreign Manufacturer” renews their accreditation, using a
form of “Application for Renewal of Accreditation” (Form No. 20 in the PAL
Enforcement Regulations), within its 5-year effective period, their accreditation
becomes null and void.
In renewing granted accreditation, they also need to submit a form of “Application for
Accreditation Examination” (Form No. 16-(2) in the Regulations) in the same way to
a new application as referred to in 2-(1) above.
When a “Deemed Accredited Foreign Manufacturer” applies for the first renewal of
their deemed accreditation after revision of the PAL, they need to attach a copy of
the certificate for their importing license, which was granted under the old PAL to
their Japanese importer called marketing approval holder under the new PAL, in
addition to take the same procedure as to obtain a new accreditation. On the other
hand, when an “Accredited Foreign Manufacturer” renews their accreditation
granted under the new PAL, they need to attach the certificate for their accreditation
to an application form for its renewal.
3. Others
(1) Notification on Change (Article 100 of the PAL Enforcement Regulations)
When an “(Deemed) Accredited Foreign Manufacturer” makes changes in the
following matters, they must notify the fact to the Minister within 30 days by
submitting a notification (Form No. 6) to PMDA.
Ⓒ Name or address of the person responsible for the manufacturing establishment
Ⓒ Name of the executives responsible for the services, when the manufacturer is a
corporation
Ⓒ Name of the manufacturing establishment
④ Major part of buildings and facilities of the manufacturing establishment
6
⑤ Category and (deemed) accreditation number, when a foreign manufacturer
obtains additional accreditations for another category, or discontinues operation
of their accredited manufacturing establishment
(2) Advising Division/Office with respect toApplication for Accreditations
1. General questions on applications and Inquiries about review status
Administration Division II, Office of Review Administration
FAX: +81-3-3506-9442
2. Examination of buildings and facilities of manufacturing establishment to be
accredited
GMP Inspection Division, Office of Compliance and Standards
(Pharmaceuticals excluding In vitro diagnostics and quasi-drugs)
FAX: +81-3-3506-9465
Medical Device Quality System Inspection Division, Office of Compliance and
Standards
(Medical devices and In vitro diagnostics)
FAX: +81-3-3506-9465
4. References(Notification and Related Documents)
 “Enforcement of Ministry Ordinances Regarding Revision of Regulations on
Manufacturing and Quality Control/Assurance of Drugs and Regulations on
Buildings and Facilities for Pharmacies etc.” Notification of Director-General of
Pharmaceutical Affairs Bureau, MHW, PAB No.1332 dated October 9, 1980.
 “Points to Be Noted in Accreditation for Foreign Manufacturers of Quasi-drugs and
Cosmetics”, the Notification of Director of Evaluation & Licensing Division,
Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD No. 0331018 dated
March 31, 2005.
 “Documents to be Attached to Application for Accreditation of Foreign
Manufacturers of Medical Devices and In vitro Diagnostics”, the Notification of
Office director of Office of Medical Devices Evaluation, Evaluation & Licensing
Division, Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD/MDE
No.0707001 dated July 7, 2005.
7
 “Q&As on Documents to be Attached to Application for Accreditation of Foreign
Manufacturers of Medical Devices and In vitro Diagnostics”, the Office
Communication Letter of Office of Medical Devices Evaluation, Evaluation &
Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; dated July 7,
2005.
 “Documents to be Attached to Applications for Accreditation of Foreign
Manufacturers of Drugs and Quasi-drugs”, the Notification of Director of Evaluation
& Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; PFSB/ELD
No. 1024002 dated October 24, 2005.
 “Q&As on Accreditation of Foreign Manufacturers”, Office Communication Letter of
Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW;
dated February 14, 2006.
 “Taxation on License and Accreditation of Manufacturers of Pharmaceuticals and
Medical Devices, etc.”, the Office Communication Letter of Evaluation & Licensing
Division, Pharmaceutical and Food Safety Bureau, MHLW; dated February 23,
2006.
 “Administrative Procedure for License and Accreditation of Marketing Business of
Pharmaceuticals and Medical Devices etc. associated with Taxation on License and
Accreditation”, the Notification of Director of Evaluation & Licensing Division and
Director of Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD No.
0331025, PFSB/SB No. 0331012 dated March 31, 2006.
 “Q&As on Documents to be Attached to Application for Accreditation of Foreign
Manufacturers of Medical Devices and In vitro Diagnostics (No.2)”, Office
Communication Letter of Office of Medical Devices Evaluation, Evaluation &
Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; dated July 27,
2006.
 “Forms to be Attached to Applications for Authorization of Manufacture of
Pharmaceuticals, etc and Accreditation of Foreign Manufacturers”, Notification of
the Director-General of Pharmaceutical and Food Safety Bureau, MHLW PFSB
No.0619002 dated June 19, 2007 (Written in Japanese but English forms are
8
available)
 “Handling of Application for Accreditation of Foreign Manufacturers” Notification of
Director of Evaluation and Licensing Division of Pharmaceutical and Food Safety
Bureau, MHLW, PFSB/ELD No.0619004 dated June 19, 2007
 “Q&As on Approval Application for Pharmaceuticals,etc”, the Office Communication
Letter of Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau,
MHLW; dated June 19, 2007
 “Accelerated procedures of change of manufacturing establishment or registration
of additional manufacturing establishment of OTC drugs“ Notification of Director of
the Evaluation and Licensing Division, Director of Compliance and Narcotics
Division, Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD No.0620001,
PFSB/CND No. 0620009 dated June 20, 2007
9
Examinations in Accreditation for Foreign Manufacturers
* In principle, document examination is required for accreditation
Applicant
(Foreign
Manufacturer)
Marketing
Approval
Holder
(1) Application to Minister
& Application for Examination
to Chief Executive, PMDA
(2) Examinations
(Document and On-site) *
(3) Inquiry, Advice,
and ReplacementOrder
(4) Response and
Replacement Notification
(7) Issue of Certificate
PMDA
(Application Received by)
Office of
Review Administration
Office of Compliance
and Standards
Office of
Review Administration
(6) Certificate
(5) Notification on Examination
Result & Application to Minister
ReplacementOrder,
when necessary
MHLW
Foreign
Manufacturing
Establishment

More Related Content

Similar to Đơn xin công nhận các nhà sản xuất nước ngoài lưu hành thuốc tại Nhật Bản

Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCTCopp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Suraj Pamadi
 
Narcotic ppt
Narcotic pptNarcotic ppt
Narcotic ppt
Prasad Bhat
 
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRYEXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
Sai Datri Arige
 
summary of indian medical device rule 2017
summary of  indian medical device rule 2017summary of  indian medical device rule 2017
summary of indian medical device rule 2017
Arshadib
 
Regulatory requirements for drug approval .pptx
Regulatory requirements for drug approval .pptxRegulatory requirements for drug approval .pptx
Regulatory requirements for drug approval .pptx
AanchalDevi
 
Medical devices rules 2015 (summary)
Medical devices rules 2015 (summary)Medical devices rules 2015 (summary)
Medical devices rules 2015 (summary)
MUHAMMAD SOHAIL
 
DECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACY
DECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACYDECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACY
DECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACY
MedGate Vietnam| Regulatory Affairs of Pharmaceutical, Medical Devices, Cosmetic
 
Overview of Japanese Foreign Manufacturers Accreditation
Overview of Japanese Foreign Manufacturers AccreditationOverview of Japanese Foreign Manufacturers Accreditation
Overview of Japanese Foreign Manufacturers Accreditation
japan-rs
 
Drug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana raoDrug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana rao
GandrapuSpandanarao
 
Regulation of herbal drugs in india
Regulation of herbal drugs in indiaRegulation of herbal drugs in india
Regulation of herbal drugs in india
Richa Patel
 
New drug approval
New drug approvalNew drug approval
New drug approval
Suvarta Maru
 
Good Regulatory Practice.pptx
Good Regulatory Practice.pptxGood Regulatory Practice.pptx
Good Regulatory Practice.pptx
Satyaji College of Pharmacy, Mehkar
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2
Jafarali Masi
 
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh AlemiPharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
ANDA, IMPD & IB
ANDA, IMPD & IBANDA, IMPD & IB
ANDA, IMPD & IB
PradipkumarRathod1
 
Distribution Setup.pdf
Distribution Setup.pdfDistribution Setup.pdf
Distribution Setup.pdf
EasyTechHome
 
A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.
A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.
A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.
Aakashdeep Raval
 
Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.  Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.
KapilKumar198
 
Lecture Lecture 16_Letter of Credit.pptx
Lecture Lecture  16_Letter of Credit.pptxLecture Lecture  16_Letter of Credit.pptx
Lecture Lecture 16_Letter of Credit.pptx
Sardar Arifuzzaman
 

Similar to Đơn xin công nhận các nhà sản xuất nước ngoài lưu hành thuốc tại Nhật Bản (20)

Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCTCopp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
 
Narcotic ppt
Narcotic pptNarcotic ppt
Narcotic ppt
 
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRYEXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
EXPORTS AND IMPORTS OF INDIAN PHARMACEUTICAL INDUSTRY
 
summary of indian medical device rule 2017
summary of  indian medical device rule 2017summary of  indian medical device rule 2017
summary of indian medical device rule 2017
 
Regulatory requirements for drug approval .pptx
Regulatory requirements for drug approval .pptxRegulatory requirements for drug approval .pptx
Regulatory requirements for drug approval .pptx
 
WorkSample#2PARA -IV FILINGS
WorkSample#2PARA -IV FILINGSWorkSample#2PARA -IV FILINGS
WorkSample#2PARA -IV FILINGS
 
Medical devices rules 2015 (summary)
Medical devices rules 2015 (summary)Medical devices rules 2015 (summary)
Medical devices rules 2015 (summary)
 
DECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACY
DECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACYDECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACY
DECREE 54/2017/ND-CP : GUIDELINES FOR IMPLEMENTATION OF THE LAW ON PHARMACY
 
Overview of Japanese Foreign Manufacturers Accreditation
Overview of Japanese Foreign Manufacturers AccreditationOverview of Japanese Foreign Manufacturers Accreditation
Overview of Japanese Foreign Manufacturers Accreditation
 
Drug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana raoDrug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana rao
 
Regulation of herbal drugs in india
Regulation of herbal drugs in indiaRegulation of herbal drugs in india
Regulation of herbal drugs in india
 
New drug approval
New drug approvalNew drug approval
New drug approval
 
Good Regulatory Practice.pptx
Good Regulatory Practice.pptxGood Regulatory Practice.pptx
Good Regulatory Practice.pptx
 
Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2Indian regulatory requirements - industrial pharmacy 2
Indian regulatory requirements - industrial pharmacy 2
 
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh AlemiPharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
 
ANDA, IMPD & IB
ANDA, IMPD & IBANDA, IMPD & IB
ANDA, IMPD & IB
 
Distribution Setup.pdf
Distribution Setup.pdfDistribution Setup.pdf
Distribution Setup.pdf
 
A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.
A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.
A) Study in detail about Para - IV filing. B) Case studies for Para - IV Filing.
 
Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.  Regulation Governing Clinical Trials In India,USA and Europe.
Regulation Governing Clinical Trials In India,USA and Europe.
 
Lecture Lecture 16_Letter of Credit.pptx
Lecture Lecture  16_Letter of Credit.pptxLecture Lecture  16_Letter of Credit.pptx
Lecture Lecture 16_Letter of Credit.pptx
 

More from Công ty Cổ phần Tư vấn Thiết kế GMP EU

Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
DANH MỤC DỰ ÁN GMP - ISO.pptx
DANH MỤC DỰ ÁN GMP - ISO.pptxDANH MỤC DỰ ÁN GMP - ISO.pptx
DANH MỤC DỰ ÁN GMP - ISO.pptx
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
ICH Q11 Combine.pdf
ICH Q11 Combine.pdfICH Q11 Combine.pdf
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptxThực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptxThực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I.pdf
GUIDE TO GOOD MANUFACTURING PRACTICE  FOR MEDICINAL PRODUCTS PART I.pdfGUIDE TO GOOD MANUFACTURING PRACTICE  FOR MEDICINAL PRODUCTS PART I.pdf
GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I.pdf
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdfDanh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
ISPE Good manufacturing practice
ISPE Good manufacturing practiceISPE Good manufacturing practice
ISPE Good manufacturing practice
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Hồ sơ năng lực GMP EU
Hồ sơ năng lực GMP EUHồ sơ năng lực GMP EU
Prequalified Active Pharmaceutical Ingredients.pptx
Prequalified Active Pharmaceutical Ingredients.pptxPrequalified Active Pharmaceutical Ingredients.pptx
Prequalified Active Pharmaceutical Ingredients.pptx
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug CarvoverFDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
FDA: Guidance-Labeling Infant Formula-March2023
FDA: Guidance-Labeling Infant Formula-March2023FDA: Guidance-Labeling Infant Formula-March2023
FDA: Guidance-Labeling Infant Formula-March2023
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 

More from Công ty Cổ phần Tư vấn Thiết kế GMP EU (20)

Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
Quyết định 878/QĐ-QLD 2023 công bố Danh mục thuốc biệt dược gốc Đợt 5
 
DANH MỤC DỰ ÁN GMP - ISO.pptx
DANH MỤC DỰ ÁN GMP - ISO.pptxDANH MỤC DỰ ÁN GMP - ISO.pptx
DANH MỤC DỰ ÁN GMP - ISO.pptx
 
ICH Q11 Combine.pdf
ICH Q11 Combine.pdfICH Q11 Combine.pdf
ICH Q11 Combine.pdf
 
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptxThực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần II.pptx
 
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptxThực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
Thực hành tốt bảo quản nguyên liệu làm thuốc (GSP) - Phần I.pptx
 
GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I.pdf
GUIDE TO GOOD MANUFACTURING PRACTICE  FOR MEDICINAL PRODUCTS PART I.pdfGUIDE TO GOOD MANUFACTURING PRACTICE  FOR MEDICINAL PRODUCTS PART I.pdf
GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I.pdf
 
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdfDanh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
Danh sách các cơ sở trong nước đạt tiêu chuẩn nguyên tắc GLP. pdf
 
ISPE Good manufacturing practice
ISPE Good manufacturing practiceISPE Good manufacturing practice
ISPE Good manufacturing practice
 
Hồ sơ năng lực GMP EU
Hồ sơ năng lực GMP EUHồ sơ năng lực GMP EU
Hồ sơ năng lực GMP EU
 
Prequalified Active Pharmaceutical Ingredients.pptx
Prequalified Active Pharmaceutical Ingredients.pptxPrequalified Active Pharmaceutical Ingredients.pptx
Prequalified Active Pharmaceutical Ingredients.pptx
 
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
Danh mục 37 thuốc sản xuất trong nước được cấp giấy phép lưu hành tại Việt Na...
 
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
Danh mục 259 thuốc sản xuất trong nước được cấp giấy đăng ký lưu hành tại Việ...
 
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
QUYẾT ĐỊNH 438/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC - ĐỢT 2 NĂ...
 
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug CarvoverFDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
FDA: Practices to Prevent Unsafe Contamunation of Animal Feed from Drug Carvover
 
FDA: Guidance-Labeling Infant Formula-March2023
FDA: Guidance-Labeling Infant Formula-March2023FDA: Guidance-Labeling Infant Formula-March2023
FDA: Guidance-Labeling Infant Formula-March2023
 
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
QUYẾT ĐỊNH 353/QĐ-QLD: Ban hành danh mục 69 thuốc sản xuất trong nước được cấ...
 
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
QUYẾT ĐỊNH SỐ 352/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 231 THUỐC SẢN XUẤT TRONG N...
 
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
QUYẾT ĐỊNH 371/QĐ-QLD VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC BIỆT DƯỢC GỐC ĐỢT 1 - NĂ...
 
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
QUYẾT ĐỊNH: 370/QĐ-QLD VỀ VIỆC BAN HÀNH DANH MỤC 50 THUỐC NƯỚC NGOÀI ĐƯỢC CẤP...
 
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
QUYẾT ĐỊNH VỀ VIỆC CÔNG BỐ DANH MỤC THUỐC CÓ CHỨNG MINH TƯƠNG ĐƯƠNG SINH HỌC ...
 

Recently uploaded

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 

Recently uploaded (20)

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 

Đơn xin công nhận các nhà sản xuất nước ngoài lưu hành thuốc tại Nhật Bản

  • 1. 1 Application for Accreditation of Foreign Manufacturers (This English document is only for reference purpose. In case of any discrepancy, the Japanese text shall prevail. For further information, please contact Ministry of Health, Labour and Welfare (MHLW) or PMDA.) 1. What is Accreditation of Foreign Manufacturers? A foreign manufacturer (a person/a company) intending to manufacture drugs, quasi- drugs, or medical devices in foreign countries and export them to Japan, is required to be accredited by the Minister of Health, Labour, and Welfare as an “Accredited Foreign Manufacturer”, specified in Article 13-3 of PAL, in the same way that a Japanese manufacturer is licensed. The person or the company who intends to apply for the accreditation is hereinafter referred to as an “Applicant”. However, a foreign manufacturer of the drug or medical device, etc. whose marketing approval holder has an effective importing license granted under the old PAL as of April 1, 2005, is deemed to be temporarily accredited under the revised PAL by the end of its effective period. The manufacturer satisfying the above condition is hereinafter referred to as a “Deemed Accredited Foreign Manufacturer”. In addition, a foreign manufacturer intending to manufacture only drug substances to be exported to Japan also need to obtain accreditation as an “Accredited Foreign Manufacturer”. The Minister of Health, Labour and Welfare has an authority to grant accreditation to a foreign manufacturer, while PMDAexamines buildings and facilities of the manufacturing establishment for accreditation. The accreditation is granted for each manufacturing establishment according to the category specified by the Enforcement Regulations. Before applying for accreditation, a Japanese marketing approval holder for an “Applicant” needs to submit “Business Number Registration Form”, reporting information on the applicant’s business and manufacturing establishments, in order to obtain “Business Number”. 2. Application for Accreditation of ForeignManufacturers (1) An “Applicant” is required to submit “Application for Accreditation” (Form No. 18 in the PAL Enforcement Regulations) that is addressed to the Minister in duplicate, and “Application for Accreditation Examination” (Form No.16-(2) in the Regulations) to Chief Executive of PMDA. Both applications need to be submitted to Administration Division II, Office of Review Administration of PMDA. A Japanese marketing approval holder who markets drugs and medical devices, etc.
  • 2. 2 manufactured by a foreign manufacturer can make an accreditation application on the manufacturer’s behalf. However, the space of “Name of Applicant” on the application form should be filled out with the foreign manufacturer’s name (when an “Applicant” is a corporation, names of the corporation and their CEO). In addition, an “Applicant” is to be responsible to renew their accreditation every 5 years. For more details on the renewal procedure, please refer to 2-(4), “Application for Renewal of Accreditation of Foreign Manufacturers”. Examination Fees for the accreditation differ between on-site and document examinations. However, PMDA requires only document audit fee to be paid to our bank account because, in principle, we do not conduct on-site inspection only for the purpose of examining buildings and facilities of a foreign manufacturing establishment to be accredited. A target period to complete administrative processing (standard administrative process time) of accrediting a foreign manufacturer is not specifically set. However, the period can be estimated to be about 5 months because the Minister’s licensing process for a domestic manufacturing establishment takes about 5 months. When an “Applicant” intends to apply for a new accreditation, they cannot apply for multiple categories in one accreditation application. They need to submit an accreditation application for one category and, at the same time, submit additional applications for the other categories (ref. 2-(3), Application for Change/Addition in Category of Accreditation of Foreign Manufacturers). (2) Documents to Be Attached to Accreditation Application (Article 35, Paragraph 2 of the PAL Enforcement Regulations) Ⓒ ”A medical certificate from a physician which indicates whether or not an “Applicant” has mental disorders or is addicted to narcotics, cannabis, opium or stimulant drugs”. (When the “Applicant” is a corporation, medical certificates of their CEO and all the executives responsible for the services are required.) A medical certificate and the other required documents for accreditation can be written in any language, but their Japanese translations are required. The reference of translator is needed only when they are written in other languages than English. When the “Applicant” is a corporation, and the Minister of Health Labour and Welfare recognizes that the above medical certificate form a physician is not an absolute necessity taking the responsible services of the executives into
  • 3. 3 consideration, a signed written statement that the relevant executives are not fall under item 3 (d) (excluding the provision of adult ward) and (e) of Article 5 of PAL can be submitted. Ⓒ “A curriculum vitae of the person who is responsible to the manufacturing establishment” Ⓒ “List of products” to be manufactured for exporting to Japan and “Documents on manufacturing process” Please make a list of products to be manufactured as detail as you can figure out by the time of accreditation application. In a “Document on manufacturing process”, please organize it clearly that each of the listed products will take what/which type of manufacturing procedure at the relevant establishment. ④ “Adocument on buildings and facilities of a manufacturing establishment” An “Applicant” intending to manufacture drugs (excluding in vitro diagnostics) and quasi-drugs needs to submit documents equivalent to the application documents for manufacturing license of drugs and quasi-drugs specified in “Enforcement of Ministerial Ordinance etc. of Partial Revision of the Regulations for Manufacturing Control and Quality Control of Drugs and Regulations for Buildings and Facilities for Pharmacies, etc.” (PAB Notification No. 1332, dated October 9, 1980). In addition, they need to submit informative documents for examination of buildings and facilities of their manufacturing establishments such as a floor plan. ⑤ “When radiopharmaceuticals are included (excluding cases that the amount of radiopharmaceuticals is equal to or less than those designated by the Minister), a document on the type of the radiopharmaceuticals and outlines of facilities for handling such radiopharmaceuticals” ⑥ “When a system for marketing license, manufacturing license, marketing approval or marketing certification of drugs and medical devices or an equivalent system is established in the country where the foreign manufacturer resides, a copy of the license certificate issued by governmental organizations etc. of the country under such system”. The license certificate should be currently valid. Note 1: Points to Consider (PTC) with Respect to Accreditation of Foreign
  • 4. 4 Manufacturers of Quasi-drugs “A medical certificate for an “Applicant” from a physician” and “a curriculum vitae of the person who is responsible for the foreign manufacturing establishment” do not need to be attached to an application form for accreditation of foreign manufacturers, when the marketing approval holder concerned responsibly ensures their reliability. In this case, the “Applicant” can omit filling out the space of “Address” in the section of “Person who is responsible for manufacturing establishment” and “Conditions of Disqualification of applicant” on the application form. In addition, the “Applicant” needs to indicate the status of their intended products by showing either “Quasi-drug Subject to GMP” or “Quasi-drug Not Subject to GMP” in the remarks column. Note 2: Points to Consider (PTC) with Respect to Accreditation of Foreign Manufacturers of Medical Devices and In vitro Diagnostics When an “Applicant” has reasonable and convincing reasons why they have difficulties to obtain their medical certificate from a physician in the country where they reside, they can submit a written self-declaration instead of a medical certificate. (3) Application for Change/Addition in Categoryof Accreditation of Foreign Manufacturers When an “Accredited Foreign Manufacturer” changes the category accredited to their manufacturing establishment or adds new categories to their accreditation, they must submit a form, “Application for Change/Addition” (Form No. 21 specified in the PAL Enforcement Regulations), in order to newly obtain the Minister’s accreditation for the change or addition. When the manufacturer intends to add new categories to their accreditation, they need to apply for addition in accreditation category. On the other hand, applying for change in category of accreditation allows the manufacturer to be accredited to new categories while cancelling their previously accredited categories. In both of the cases, the manufacturer also needs to submit a form of “Application for Accreditation Examination” (Form No. 16-(2) in the Regulations) in the same way of a new application as referred to in 2-(1) above. The documents required for change or addition in category of accreditation of
  • 5. 5 foreign manufacturers are as follows; (Article 31 of the PAL Enforcement Regulations shall apply mutatis mutandis to Article 37.) 1. Accreditation certificate 2. List of products whose accreditation category to be changed or added and documents on their manufacturing processes 3. Documents on buildings and facilities of a manufacturing establishment that relates to change or addition in category of accreditation (4) Application for Renewal of Accreditation of Foreign Manufacturers Unless an “Accredited Foreign Manufacturer” renews their accreditation, using a form of “Application for Renewal of Accreditation” (Form No. 20 in the PAL Enforcement Regulations), within its 5-year effective period, their accreditation becomes null and void. In renewing granted accreditation, they also need to submit a form of “Application for Accreditation Examination” (Form No. 16-(2) in the Regulations) in the same way to a new application as referred to in 2-(1) above. When a “Deemed Accredited Foreign Manufacturer” applies for the first renewal of their deemed accreditation after revision of the PAL, they need to attach a copy of the certificate for their importing license, which was granted under the old PAL to their Japanese importer called marketing approval holder under the new PAL, in addition to take the same procedure as to obtain a new accreditation. On the other hand, when an “Accredited Foreign Manufacturer” renews their accreditation granted under the new PAL, they need to attach the certificate for their accreditation to an application form for its renewal. 3. Others (1) Notification on Change (Article 100 of the PAL Enforcement Regulations) When an “(Deemed) Accredited Foreign Manufacturer” makes changes in the following matters, they must notify the fact to the Minister within 30 days by submitting a notification (Form No. 6) to PMDA. Ⓒ Name or address of the person responsible for the manufacturing establishment Ⓒ Name of the executives responsible for the services, when the manufacturer is a corporation Ⓒ Name of the manufacturing establishment ④ Major part of buildings and facilities of the manufacturing establishment
  • 6. 6 ⑤ Category and (deemed) accreditation number, when a foreign manufacturer obtains additional accreditations for another category, or discontinues operation of their accredited manufacturing establishment (2) Advising Division/Office with respect toApplication for Accreditations 1. General questions on applications and Inquiries about review status Administration Division II, Office of Review Administration FAX: +81-3-3506-9442 2. Examination of buildings and facilities of manufacturing establishment to be accredited GMP Inspection Division, Office of Compliance and Standards (Pharmaceuticals excluding In vitro diagnostics and quasi-drugs) FAX: +81-3-3506-9465 Medical Device Quality System Inspection Division, Office of Compliance and Standards (Medical devices and In vitro diagnostics) FAX: +81-3-3506-9465 4. References(Notification and Related Documents)  “Enforcement of Ministry Ordinances Regarding Revision of Regulations on Manufacturing and Quality Control/Assurance of Drugs and Regulations on Buildings and Facilities for Pharmacies etc.” Notification of Director-General of Pharmaceutical Affairs Bureau, MHW, PAB No.1332 dated October 9, 1980.  “Points to Be Noted in Accreditation for Foreign Manufacturers of Quasi-drugs and Cosmetics”, the Notification of Director of Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD No. 0331018 dated March 31, 2005.  “Documents to be Attached to Application for Accreditation of Foreign Manufacturers of Medical Devices and In vitro Diagnostics”, the Notification of Office director of Office of Medical Devices Evaluation, Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD/MDE No.0707001 dated July 7, 2005.
  • 7. 7  “Q&As on Documents to be Attached to Application for Accreditation of Foreign Manufacturers of Medical Devices and In vitro Diagnostics”, the Office Communication Letter of Office of Medical Devices Evaluation, Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; dated July 7, 2005.  “Documents to be Attached to Applications for Accreditation of Foreign Manufacturers of Drugs and Quasi-drugs”, the Notification of Director of Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; PFSB/ELD No. 1024002 dated October 24, 2005.  “Q&As on Accreditation of Foreign Manufacturers”, Office Communication Letter of Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; dated February 14, 2006.  “Taxation on License and Accreditation of Manufacturers of Pharmaceuticals and Medical Devices, etc.”, the Office Communication Letter of Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; dated February 23, 2006.  “Administrative Procedure for License and Accreditation of Marketing Business of Pharmaceuticals and Medical Devices etc. associated with Taxation on License and Accreditation”, the Notification of Director of Evaluation & Licensing Division and Director of Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD No. 0331025, PFSB/SB No. 0331012 dated March 31, 2006.  “Q&As on Documents to be Attached to Application for Accreditation of Foreign Manufacturers of Medical Devices and In vitro Diagnostics (No.2)”, Office Communication Letter of Office of Medical Devices Evaluation, Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; dated July 27, 2006.  “Forms to be Attached to Applications for Authorization of Manufacture of Pharmaceuticals, etc and Accreditation of Foreign Manufacturers”, Notification of the Director-General of Pharmaceutical and Food Safety Bureau, MHLW PFSB No.0619002 dated June 19, 2007 (Written in Japanese but English forms are
  • 8. 8 available)  “Handling of Application for Accreditation of Foreign Manufacturers” Notification of Director of Evaluation and Licensing Division of Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD No.0619004 dated June 19, 2007  “Q&As on Approval Application for Pharmaceuticals,etc”, the Office Communication Letter of Evaluation & Licensing Division, Pharmaceutical and Food Safety Bureau, MHLW; dated June 19, 2007  “Accelerated procedures of change of manufacturing establishment or registration of additional manufacturing establishment of OTC drugs“ Notification of Director of the Evaluation and Licensing Division, Director of Compliance and Narcotics Division, Pharmaceutical and Food Safety Bureau, MHLW, PFSB/ELD No.0620001, PFSB/CND No. 0620009 dated June 20, 2007
  • 9. 9 Examinations in Accreditation for Foreign Manufacturers * In principle, document examination is required for accreditation Applicant (Foreign Manufacturer) Marketing Approval Holder (1) Application to Minister & Application for Examination to Chief Executive, PMDA (2) Examinations (Document and On-site) * (3) Inquiry, Advice, and ReplacementOrder (4) Response and Replacement Notification (7) Issue of Certificate PMDA (Application Received by) Office of Review Administration Office of Compliance and Standards Office of Review Administration (6) Certificate (5) Notification on Examination Result & Application to Minister ReplacementOrder, when necessary MHLW Foreign Manufacturing Establishment